{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T01:47:04Z","timestamp":1781920024983,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Science and Technology Development Program of Jilin Province","award":["20160520046JH"],"award-info":[{"award-number":["20160520046JH"]}]},{"name":"Science and Technology Development Program of Jilin Province","award":["20140203012YY"],"award-info":[{"award-number":["20140203012YY"]}]},{"DOI":"10.13039\/501100001809","name":"NSFC","doi-asserted-by":"publisher","award":["81602654"],"award-info":[{"award-number":["81602654"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"NSFC","doi-asserted-by":"publisher","award":["82102953"],"award-info":[{"award-number":["82102953"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Development Program of Jilin City in Jilin Province","award":["201464053"],"award-info":[{"award-number":["201464053"]}]},{"DOI":"10.13039\/501100004945","name":"Nankai University","doi-asserted-by":"publisher","award":["201503001"],"award-info":[{"award-number":["201503001"]}],"id":[{"id":"10.13039\/501100004945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2015M571373"],"award-info":[{"award-number":["2015M571373"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010211","name":"Education Department of Jilin Province","doi-asserted-by":"publisher","award":["2015-401"],"award-info":[{"award-number":["2015-401"]}],"id":[{"id":"10.13039\/501100010211","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ejps.2019.01.019","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T10:16:20Z","timestamp":1548411380000},"page":"78-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Hot melt extrusion technology for improved dissolution, solubility and \u201cspring-parachute\u201d processes of amorphous self-micellizing solid dispersions containing BCS II drugs indomethacin and fenofibrate: Profiles and mechanisms"],"prefix":"10.1016","volume":"130","author":[{"given":"Nian-Qiu","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Ran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Shuang","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Na","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Hui","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Rong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2019.01.019_bb0005","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2019.01.019_bb0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jps.22750","article-title":"Supersaturating drug delivery systems: fast is not necessarily good enough","volume":"101","author":"Augustijns","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2019.01.019_bb0015","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.addr.2011.07.009","article-title":"Evaluation of amorphous solid dispersion properties using thermal analysis techniques","volume":"64","author":"Baird","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2019.01.019_bb0020","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1517\/17425247.2011.618181","article-title":"Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs","volume":"8","author":"Bikiaris","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2019.01.019_bb0025","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1002\/jps.21650","article-title":"Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?","volume":"98","author":"Brouwers","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2019.01.019_bb0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejps.2013.04.002","article-title":"Biopharmaceutical classification of poorly soluble drugs with respect to \u201cenabling formulations\u201d","volume":"50","author":"Buckley","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2019.01.019_bb0035","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijpharm.2017.05.005","article-title":"Microemulsion utility in pharmaceuticals: implications for multi-drug delivery","volume":"526","author":"Callender","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2019.01.019_bb0040","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.addr.2015.12.009","article-title":"Recent advances in co-amorphous drug formulations","volume":"100","author":"Dengale","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2019.01.019_bb0045","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2017.04.015","article-title":"Mechanism-based selection of stabilization strategy for amorphous formulations: insights into crystallization pathways","volume":"256","author":"Edueng","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2019.01.019_bb0050","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejps.2014.05.022","article-title":"A novel concentration dependent amino acid ion pair strategy to mediate drug permeation using indomethacin as a model insoluble drug","volume":"62","author":"ElShaer","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2019.01.019_bb0055","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0022-3549(15)00186-0","article-title":"Solid phospholipid dispersions for oral delivery of poorly soluble drugs: investigation into celecoxib incorporation and solubility-in vitro permeability enhancement","volume":"105","author":"Fong","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2019.01.019_bb0060","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/17425247.2016.1218465","article-title":"Oral bioavailability enhancement through supersaturation: an update and meta-analysis","volume":"14","author":"Fong","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2019.01.019_bb0065","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ijpharm.2012.08.014","article-title":"Amorphous solid dispersion enhances permeation of poorly soluble ABT-102: true supersaturation vs. apparent solubility enhancement","volume":"437","author":"Frank","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2019.01.019_bb0070","first-page":"5757","article-title":"The amorphous solid dispersion of the poorly soluble ABT-102 forms nano\/microparticulate structures in aqueous medium: impact on solubility","volume":"7","author":"Frank","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejps.2019.01.019_bb0075","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/jps.23979","article-title":"What is the mechanism behind increased permeation rate of a poorly soluble drug from aqueous dispersions of an amorphous solid dispersion?","volume":"103","author":"Frank","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2019.01.019_bb0080","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jconrel.2017.08.031","article-title":"Exploring intracellular fate of drug nanocrystals with crystal-integrated and environment-sensitive fluorophores","volume":"267","author":"Gao","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2019.01.019_bb0085","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1248\/cpb.c14-00030","article-title":"Preparation and evaluation of solid dispersion of atorvastatin calcium with Soluplus\u00ae by spray drying technique","volume":"62","author":"Ha","year":"2014","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejps.2019.01.019_bb0090","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ejps.2018.01.039","article-title":"Evaluation and optimized selection of supersaturating drug delivery systems of posaconazole (BCS class 2b) in the gastrointestinal simulator (GIS): an in vitro-in silico-in vivo approach","volume":"115","author":"Hens","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2019.01.019_bb0095","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1002\/jps.20537","article-title":"Bioavailability and in vivo release behavior of controlled-release multiple-unit theophylline dosage forms in beagle dogs, cynomolgus monkeys, and g\u00f6ttingen minipigs","volume":"95","author":"Ikegami","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2019.01.019_bb0100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2017.07.069","article-title":"Early pediatric formulation development with new chemical entities: opportunities of e-tongue besides human taste assessment","volume":"530","author":"Immohr","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2019.01.019_bb0105","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejps.2018.11.003","article-title":"A dynamic in vitro permeation study on solid mono- and diacyl-phospholipid dispersions of celecoxib","volume":"127","author":"Jacobsen","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2019.01.019_bb0110","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.addr.2011.10.009","article-title":"Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs","volume":"64","author":"Kawakami","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2019.01.019_bb0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejps.2016.10.032","article-title":"Improved oral absorption profile of itraconazole in hypochlorhydria by self-micellizing solid dispersion approach","volume":"97","author":"Kojo","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2019.01.019_bb0120","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.dmpk.2017.06.001","article-title":"Avoidance of food effect on oral absorption profile of itraconazole by self-micellizing solid dispersion approach","volume":"32","author":"Kojo","year":"2017","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejps.2019.01.019_bb0125","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejps.2017.02.003","article-title":"Dissolution and dissolution\/permeation experiments for predicting systemic exposure following oral administration of the BCS class II drug clarithromycin","volume":"101","author":"Kristin","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2019.01.019_bb0130","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2016018537","article-title":"Advanced implantable drug delivery systems via continuous manufacturing","volume":"33","author":"Maniruzzaman","year":"2016","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.ejps.2019.01.019_bb0135","first-page":"19","article-title":"Self-micellizing solid dispersion of cyclosporine A with improved dissolution and oral bioavailability","volume":"545","author":"Onoue","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2019.01.019_bb0140","article-title":"Population balance model for simulation of the supersaturation-precipitation behavior of drugs in supersaturable solid forms","volume":"Aug 6","author":"Ozaki","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2019.01.019_bb0145","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejpb.2015.10.013","article-title":"\u03b2-Cyclodextrin complexation as an effective drug delivery system for meropenem","volume":"99","author":"Paczkowska","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2019.01.019_bb0150","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijpharm.2016.04.013","article-title":"Prediction of positive food effect: bioavailability enhancement of BCS class II drugs","volume":"506","author":"Raman","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2019.01.019_bb0155","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijpharm.2017.10.056","article-title":"Melt extrusion with poorly soluble drugs - an integrated review","volume":"535","author":"Repka","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2019.01.019_bb0160","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/j.vaccine.2017.03.012","article-title":"Nano-sized Soluplus\u00ae polymeric micelles enhance the induction of tetanus toxin neutralising antibody response following transcutaneous immunisation with tetanus toxoid","volume":"35","author":"Saydam","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.ejps.2019.01.019_bb0165","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijpharm.2018.02.039","article-title":"Interdependence of particle properties and bulk powder behavior of indomethacin in quench-cooled molten two-phase solid dispersions","volume":"541","author":"Semjonov","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2019.01.019_bb0170","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1016\/j.xphs.2015.12.006","article-title":"Theoretical analysis of drug dissolution: I. Solubility and intrinsic dissolution rate","volume":"105","author":"Shekunov","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2019.01.019_bb0175","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.powtec.2013.06.039","article-title":"Impact of amorphous and semicrystalline polymers on the dissolution and crystallization inhibition of pioglitazone solid dispersions","volume":"247","author":"Shi","year":"2013","journal-title":"Powder Technol."},{"key":"10.1016\/j.ejps.2019.01.019_bb0180","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3109\/03639045.2013.809536","article-title":"Effect of polymers and media type on extending the dissolution of amorphous pioglitazone and inhibiting the recrystallization from a supersaturated state","volume":"40","author":"Shi","year":"2014","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2019.01.019_bb0185","doi-asserted-by":"crossref","first-page":"41767","DOI":"10.1021\/acsami.7b15523","article-title":"Intelligent \u201cPeptide-Gathering Mechanical Arm\u201d tames wild \u201cTrojan-Horse\u201d peptides for the controlled delivery of cancer nanotherapeutics","volume":"9","author":"Shi","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejps.2019.01.019_bb0190","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ijpharm.2017.06.017","article-title":"Self-micellizing solid dispersions enhance the properties and therapeutic potential of fenofibrate: advantages, profiles and mechanisms","volume":"528","author":"Shi","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2019.01.019_bb0195","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/10837450.2016.1256409","article-title":"On the inherent properties of Soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology","volume":"23","author":"Shi","year":"2018","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejps.2019.01.019_bb0200","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.2147\/IJN.S172556","article-title":"Deepened cellular\/subcellular interface penetration and enhanced antitumor efficacy of cyclic peptidic ligand-decorated accelerating active targeted nanomedicines","volume":"13","author":"Shi","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejps.2019.01.019_bb0205","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-018-1266-y","article-title":"The influence of cellulosic polymer's variables on dissolution\/solubility of amorphous felodipine and crystallization inhibition from a supersaturated state","author":"Shi","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2019.01.019_bb0210","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/tcr.20050","article-title":"Applications of X-ray powder diffraction in materials chemistry","volume":"5","author":"Skakle","year":"2005","journal-title":"Chem. Rec."},{"key":"10.1016\/j.ejps.2019.01.019_bb0215","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.drudis.2015.01.012","article-title":"Polymeric formulations for drug release prepared by hot melt extrusion: application and characterization","volume":"20","author":"Stankovi\u0107","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2019.01.019_bb0220","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejps.2016.09.015","article-title":"Self-micellizing solid dispersion of cyclosporine A for pulmonary delivery: physicochemical, pharmacokinetic and safety assessments","volume":"96","author":"Suzuki","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2019.01.019_bb0225","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1517\/17425247.2016.1126246","article-title":"Contribution of hot-melt extrusion technology to advance drug delivery in the 21st century","volume":"13","author":"Tiwari","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2019.01.019_bb0230","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1007\/s11095-017-2186-3","article-title":"Scanning electron microscope observations of powder sticking on punches during a limited number (N\u202f<\u202f5) of compactions of acetylsalicylic acid","volume":"34","author":"Tsosie","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2019.01.019_bb0235","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1063\/1.1747055","article-title":"Rate of nucleation in condensed systems","volume":"17","author":"Turnbull","year":"1949","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejps.2019.01.019_bb0240","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.drudis.2007.09.005","article-title":"Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs","volume":"12","author":"Vasconcelos","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2019.01.019_bb0245","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijpharm.2013.05.013","article-title":"Drug precipitation inhibitors in supersaturable formulations","volume":"453","author":"Xu","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2019.01.019_bb0250","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijpharm.2018.11.010","article-title":"Development and in vitro evaluation of a self-emulsifying drug delivery system (SEDDS) for oral vancomycin administration","volume":"554","author":"Zaichik","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2019.01.019_bb0255","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3109\/03639045.2014.913613","article-title":"Deoxycholic acid-grafted PEGylated chitosan micelles for the delivery of mitomycin C","volume":"41","author":"Zhang","year":"2015","journal-title":"Drug Dev. Ind. Pharm."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098719300296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098719300296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T19:44:45Z","timestamp":1565207085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098719300296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":51,"alternative-id":["S0928098719300296"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2019.01.019","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hot melt extrusion technology for improved dissolution, solubility and \u201cspring-parachute\u201d processes of amorphous self-micellizing solid dispersions containing BCS II drugs indomethacin and fenofibrate: Profiles and mechanisms","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2019.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}